| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0479 | Ads-j1 | Inhibitor of semen-derived amyloid fibril formation, blocking fibril-mediated enhancement of HIV-1 infection |
|
| DCC0480 | Adt-061 | Novel PDE10 inhibitor, reducing oncogenic β-catenin, suppressing TCF/LEF transcription |
|
| DCC0481 | Adtl-ei1712 | The first selective dual-target inhibitor of ERK1 and ERK5 |
|
| DCC0482 | Adx61623 | Novel Nonsteroidal Negative Allosteric Modulator of Follicle-Stimulating Hormone Receptor (FSHR) |
|
| DCC0483 | Adx68692 | Novel Nonsteroidal Negative Allosteric Modulator of Follicle-Stimulating Hormone Receptor (FSHR) |
|
| DCC0484 | Adx68693 | Novel inhibitor of hFSHR (104 nM) and hLHR (314 nM), showing no activity with hTSHR at 30 μM |
|
| DCC0485 | aeg3482 Sodium Salt | Novel inhibitor of Jun kinase activity and cell death through induced expression of heat shock protein 70 |
|
| DCC0486 | Aerobactin | Bacterial iron chelating agent as a siderophore and an Escherichia coli metabolite |
|
| DCC0487 | Af3442 | Novel inhibitor of human microsomal prostaglandin E synthase-1 (mPGES-1) |
|
| DCC0488 | af-353 Hydrochloride | Potent antagonist of P2X3 and P2X2/3 |
|
| DCC0489 | Af-399/42018025 | Novel CC chemokine receptor 4 (CCR4) antagonist |
|
| DCC0490 | Aflatoxin B1 | Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $36.45 Total: $3,645.00 50 $42.12 Total: $2,106.00 25 $49.41 Total: $1,235.25 10 $58.32 Total: $583.20 5 $68.85 Total: $344.25 |
|
| DCC0491 | Aflatoxin B2 | Natural Potent Hepatocarcinogen |
|
| DCC0492 | Afn941 | Staurosporine analog, acting as a Jak3-specific inhibitor |
|
| DCC0493 | Aftobetin | Probe used for Early detection of Alzheimer's disease |
|
| DCC0494 | Ag-012986 | pan-Cyclin dependent kinase (CDK) inhibitor |
|
| DCC0496 | Ag1433 | Potent inhibitor of tyrosine kinases; Direct and selective inhibitor of photosynthetic PEP carboxylase; Inhibitor of PDGFR-β, Flk-1, and angiogenesis |
|
| DCC0497 | Ag1529 | Novel capsaicinoid-based soft drug, attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability |
|
| DCC0498 | Ag2034 | Inhibitor of the glycinamide ribonucleotide formyltransferase (GARFT) |
|
| DCC0499 | Ag-5473 | Novel potent FKBP12 ligand |
|
| DCC0500 | Ag-5507 | Novel potent FKBP12 ligand |
|
| DCC0501 | Agamanone | Anticancer agent with antioxidant and chemopreventive properties |
|
| DCC0502 | Agathisflavone | Inhibitor of NS2B-NS3 proteases of the Dengue virus serotypes 2 and 3 |
|
| DCC0503 | Agi-134 | Novel inducer of anti-tumor immunity, converting tumors into in situ autologous vaccines |
|
| DCC0504 | Agi-24512 | Novel methionine adenosyltransferase 2A (MATA2 ) inhibitor |
|
| DCC0505 | Agn193312 | Novel potent and selective RARα inhibitor |
|
| DCC0506 | Agn193836 | Retinoic Acid Receptor α Subtype Specific Agonist |
|
| DCC0507 | Agn194301 | Novel potent and specific RARα antagonist |
|
| DCC0508 | Agn199108 | Inhibitor of the basal proton conductance of UCP1; Retinoid, displaying a nonspecific stimulation of NADH oxidation in control mitochondria |
|
| DCC0509 | Agn-201781 | alpha Adrenoceptor agonist for the treatment of neuropathic pain |
|
